BioStem Technologies, Inc. BSEM
NASDAQ · United States · Health Technology
$2.73-0.34 (-11.07%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.52 | -0.50 | -4.0% | $7.90M | +24.4% | -14.1%$3.61→$3.10 |
| Q1 2026 | 2026-05-14 | -0.52 | -0.28 | -85.7% | — | — | -14.9%$5.07→$4.32 |
| Q4 2025 | 2026-03-24 | -0.01 | 0.02 | -150.0% | — | — | -10.4%$5.49→$4.92 |
| Q3 2025 | 2025-11-13 | 0.06 | 0.00 | — | — | — | -14.5%$4.65→$3.97 |
| Q2 2025 | 2025-08-13 | 0.11 | 0.32 | -65.6% | — | — | — |
| Q1 2025 | 2025-05-11 | 0.27 | 1.25 | -78.4% | — | — | — |
| Q4 2024 | 2025-04-14 | 0.79 | 0.37 | +113.5% | — | — | — |
| Q3 2024 | 2024-11-11 | 0.34 | 0.36 | -5.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.